RT Journal Article
SR Electronic
T1 Molecular identification of SARS-CoV-2 variants of concern at urban wastewater treatment plants across South Africa
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.12.15.22283506
DO 10.1101/2022.12.15.22283506
A1 Yousif, Mukhlid
A1 Rachida, Said
A1 Taukobong, Setshaba
A1 Ndlovu, Nkosenhle
A1 Iwu-Jaja, Chinwe
A1 Howard, Wayne
A1 Moonsamy, Shelina
A1 Mhlambi, Nompilo
A1 Gwala, Sipho
A1 Levy, Joshua I.
A1 Andersen, Kristian G.
A1 Scheepers, Cathrine
A1 Gottberg, Anne von
A1 Wolter, Nicole
A1 Ismail, Arshad
A1 Suchard, Melinda
A1 McCarthy, Kerrigan
A1 ,
YR 2022
UL http://medrxiv.org/content/early/2022/12/16/2022.12.15.22283506.abstract
AB The use of wastewater for SARS-CoV-2 surveillance is a useful complementary tool to clinical surveillance. The aims of this study were to characterize SARS-CoV-2 from wastewater samples, and to identify variants of concern present in samples collected from wastewater treatment plants in South African urban metros from April 2021 to January 2022. A total of 325 samples were collected from 15 wastewater treatment plants. Nucleic acids were extracted from concentrated samples, and subjected to amplicon-based whole genome sequencing. To identify variants of concerns and lineages, we used the Freyja tool (https://github.com/andersen-lab/Freyja), which assigns each sample with the prevalence of each variant present. We also used signature mutation analysis to identify variants in each wastewater treatment site. A heatmap was generated to identify patterns of emerging mutations in the spike gene using Excel conditional formatting. Using the Freyja tool, the Beta variant was detected and became predominate from April to June 2021 followed by the Delta variant and lastly the Omicron variant. Our heatmap approach was able to identify a pattern during the changes of predominate variant in wastewater with the emergence of mutations and the loss of others. In conclusion, sequencing of SARS-CoV-2 from wastewater largely corresponded with sequencing from clinical specimens. Our heatmap has the potential to detect new variants prior to emergence in clinical samples and this may be particularly useful during times of low disease incidence between waves, when few numbers of positive clinical samples are collected and submitted for testing. A limitation of wastewater sequencing is that it is not possible to identify new variants, as variants are classified based on known mutations in clinical strains.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the National Institute for Communicable Diseases (NICD) of South Africa, the Water Research Commission (WRC) of South Africa, the German Society for International Cooperation (GIZ) and Bill and Melinda Gates foundation (BMGF), and Africa CDC.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript